tiprankstipranks
Trending News
More News >
Immuneering (IMRX)
NASDAQ:IMRX
US Market

Immuneering (IMRX) Cash flow

Compare
648 Followers

Immuneering Cash Flow

IMRX's free cash flow for Q4 2025 was $-9.96M. For the 2025 fiscal year, IMRX's free cash flow was decreased by $9.60M and operating cash flow was $-9.84M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -45.34M$ -55.00M$ -48.97M$ -44.10M$ -30.85M
Investing Cash Flow
$ -88.74M$ 26.43M$ 7.30M$ 41.83M$ -75.62M
Financing Cash Flow
$ 226.58M$ 5.30M$ 28.44M$ 19.00K$ 144.26M
End Cash Position
$ 128.65M$ 36.14M$ 59.41M$ 72.64M$ 74.89M
Free Cash Flow
$ -45.49M$ -55.08M$ -49.31M$ -44.84M$ -30.91M
Currency in USD

Immuneering Cash Flow